Skip to main content

Atle Fund Management AB

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1381843 STOCKHOLM, V7

Position in BBIO

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$9,288,177
+$1,018,361 QoQ
Shares Held
124,707
+12.0% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
2.50%
of 13F equity value
Holder Rank
#122
of 467 holders
Holding Since
Dec 2022
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Atle Fund Management AB holds $141,162,145 across 21 Biotechnology names. BBIO ranks #6 (6.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 BBIO
BridgeBio Pharma, Inc.
This page
124,707 $9,288,177

All Filings in BBIO

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,288,177 124,707
2026-03-31 $8,269,816 111,363
2025-12-31 $10,807,731 141,296
2025-09-30 $963,444 174,722
2025-06-30 $7,145,426 165,480
2025-03-31 $5,232,100 151,348
2024-12-31 $2,827,198 103,032
2024-09-30 $1,360,378 53,432
2024-06-30 $1,353,432 53,432
2024-03-31 $1,170,043 37,841
2023-12-31 $968,274 23,985
2022-12-31 $6,758 887